At a glance
- Originator Merck & Co
- Class Antithrombotics
- Mechanism of Action Thrombin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Thrombosis
Most Recent Events
- 24 Apr 1998 Investigation in Thrombosis in USA (Unknown route)
- 08 Dec 1997 Preclinical development for Thrombosis in USA (Unknown route)
- 29 Sep 1997 New profile